Liver Cancer News and Research

RSS

Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.

Testing for alpha fetoprotein may improve early liver cancer detection, finds study

A new study found that ultrasound imaging in combination with a blood test for alpha fetoprotein improved the detection of early-stage liver cancer by 40%.

12 Feb 2018

Combining ultrasound with blood test improves detection of liver cancer by 40%

Combining ultrasound imaging with a blood test for high alpha fetoprotein levels improves detection of early-stage liver cancer by as much as 40 percent, researchers at UT Southwestern's Simmons Cancer Center found.

11 Feb 2018

Cholesterol and other lipids in the blood play role in many diseases

Lipids are fatty molecules that play important signaling and storage roles in the body, but having an excess of some lipids, like cholesterol, is a risk factor for many metabolic diseases.

8 Feb 2018

Scientists find new way to kill liver cancer cells

Scientists at the University of Delaware and the University of Illinois at Chicago have found a new way to kill liver cancer cells and inhibit tumor growth. First, they silence a key cellular enzyme, and then they add a powerful drug.

7 Feb 2018

IU scientists take important step to fight against hepatitis B with 'virus-cracking' molecules

Indiana University researchers have made an important step forward in the design of drugs that fight the hepatitis B virus, which can cause liver failure and liver cancer.

7 Feb 2018

New discovery could be key to stopping damage caused by inflammation in many diseases

A discovery by Queensland scientists could be the key to stopping damage caused by uncontrolled inflammation in a range of common diseases including liver disease, Alzheimer's and gout.

7 Feb 2018

Deaths caused by liver cancer have increased by 80% over last two decades

Over the last two decades, deaths caused by liver cancer have increased by 80%, making it one of the fastest-growing causes of cancer deaths worldwide.

1 Feb 2018

Microbubbles increase radiotherapy success against breast cancer

A new study found that injecting microbubbles filled with oxygen into breast cancer tumors makes them three times more sensitive to radiotherapy.

1 Feb 2018

Long-term intake of sunflower, fish oils affects the liver

An international group of scientists led by the University of Granada (UGR) has demonstrated that the long-term intake of sunflower or fish oils damages the liver and can cause a series of alterations in it, giving rise to non-alcoholic steatohepatitis.

31 Jan 2018

Oxygen-filled microbubbles make breast tumors more sensitive to radiation therapy

Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to radiation therapy and improves survival in animal models of the disease.

30 Jan 2018

NUS scientists develop new way to wirelessly deliver light for cancer treatment

A team of scientists from the National University of Singapore has developed a way to wirelessly deliver light into deep regions of the body to activate light-sensitive drugs for photodynamic therapy.

30 Jan 2018

UT Southwestern oncologist highlights need to improve liver cancer screening rates

Patients with cirrhosis should be screened regularly for liver cancer, though few are – in part because busy physicians often don't order the screening tests, said UT Southwestern oncologists.

30 Jan 2018

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

A new Practice Guideline and Practice Guidance in Hepatology will help improve the diagnosis and treatment of patients with liver cancer as well as patients with non-alcoholic fatty liver disease (NAFLD), which can lead to liver cancer and is characterized by the build-up of extra fat in liver cells often due to obesity and diabetes.

27 Jan 2018

Biomarkers may help predict prognosis of gastric cancer patients with alcohol consumption habits

Alcohol consumption has been identified as a modifiable risk factor for cancers such as gastric cancer. A new report in the The American Journal of Pathology sheds light on how specific proteins interact with alcohol, and how that interplay impacts survival and response to platinum-based adjuvant chemotherapy in patients with gastric cancer who may or may not still be drinking.

10 Jan 2018

Cancer death rate continues decades-long drop in the United States

The cancer death rate dropped 1.7% from 2014 to 2015, continuing a drop that began in 1991 and has reached 26%, resulting in nearly 2.4 million fewer cancer deaths during that time.

4 Jan 2018

Nanobiotix receives FDA approval for first immuno-oncology trial

NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).

26 Dec 2017

Emerging pharmacologic approach may inhibit NASH

Treating a liver disease called NASH (non-alcoholic steatohepatitis), which affects 10 to 15 percent of obese individuals with type-2 diabetes worldwide, is difficult. But now scientists believe they have found a pharmacologic approach that may inhibit NASH, and thus stop deadly conditions that result from NASH such as cirrhosis and liver cancer.

21 Dec 2017

Study paves way for new therapeutic strategies to impede growth of virus-induced cancers

Researchers at the Cancer Science Institute of Singapore at the National University of Singapore have identified a novel molecular pathway by which a tumor suppressor, TIP60, inhibits the growth of cancer cells.

7 Dec 2017

Nearly 6% of cancers worldwide caused by diabetes and high BMI, study finds

Diabetes and high BMI (a BMI over 25 kg/m2) were the cause of 5.6% of new cancer cases worldwide in 2012 – equivalent to 792600 cases, according to the first study to quantify the proportion of cancers attributable to diabetes and high BMI published in The Lancet Diabetes & Endocrinology journal.

5 Dec 2017

Moderate coffee consumption more likely to provide beneficial health outcomes

Drinking coffee is "more likely to benefit health than to harm it" for a range of health outcomes, say researchers in The BMJ today.

23 Nov 2017

Liver Cancer News and Research

Further Reading

Testing for alpha fetoprotein may improve early liver cancer detection, finds study

Combining ultrasound with blood test improves detection of liver cancer by 40%

Cholesterol and other lipids in the blood play role in many diseases

Scientists find new way to kill liver cancer cells

IU scientists take important step to fight against hepatitis B with 'virus-cracking' molecules

New discovery could be key to stopping damage caused by inflammation in many diseases

Deaths caused by liver cancer have increased by 80% over last two decades

Microbubbles increase radiotherapy success against breast cancer

Long-term intake of sunflower, fish oils affects the liver

Oxygen-filled microbubbles make breast tumors more sensitive to radiation therapy

NUS scientists develop new way to wirelessly deliver light for cancer treatment

UT Southwestern oncologist highlights need to improve liver cancer screening rates

New AASLD guideline focuses on improving diagnosis, treatment of liver cancer and NAFLD

Biomarkers may help predict prognosis of gastric cancer patients with alcohol consumption habits

Cancer death rate continues decades-long drop in the United States

Nanobiotix receives FDA approval for first immuno-oncology trial

Emerging pharmacologic approach may inhibit NASH

Study paves way for new therapeutic strategies to impede growth of virus-induced cancers

Nearly 6% of cancers worldwide caused by diabetes and high BMI, study finds

Moderate coffee consumption more likely to provide beneficial health outcomes

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News